412 related articles for article (PubMed ID: 8229747)
1. Mu- and delta-opioid receptors inhibitorily linked to dopamine-sensitive adenylate cyclase in rat striatum display a selectivity profile toward endogenous opioid peptides different from that of presynaptic mu, delta and kappa receptors.
Schoffelmeer AN; De Vries TJ; Hogenboom F; Mulder AH
J Pharmacol Exp Ther; 1993 Oct; 267(1):205-10. PubMed ID: 8229747
[TBL] [Abstract][Full Text] [Related]
2. Mu- and delta-opioid receptor-mediated inhibition of adenylate cyclase activity stimulated by released endogenous dopamine in rat neostriatal slices; demonstration of potent delta-agonist activity of bremazocine.
Heijna MH; Hogenboom F; Portoghese PS; Mulder AH; Schoffelmeer AN
J Pharmacol Exp Ther; 1989 Jun; 249(3):864-8. PubMed ID: 2543814
[TBL] [Abstract][Full Text] [Related]
3. Mu-, delta- and kappa-opioid receptor-mediated inhibition of neurotransmitter release and adenylate cyclase activity in rat brain slices: studies with fentanyl isothiocyanate.
Schoffelmeer AN; Rice KC; Jacobson AE; Van Gelderen JG; Hogenboom F; Heijna MH; Mulder AH
Eur J Pharmacol; 1988 Sep; 154(2):169-78. PubMed ID: 2906610
[TBL] [Abstract][Full Text] [Related]
4. Dopamine displays an identical apparent affinity towards functional dopamine D1 and D2 receptors in rat striatal slices: possible implications for the regulatory role of D2 receptors.
Schoffelmeer AN; Hogenboom F; Mulder AH; Ronken E; Stoof JC; Drukarch B
Synapse; 1994 Jul; 17(3):190-5. PubMed ID: 7974202
[TBL] [Abstract][Full Text] [Related]
5. Beta-endorphin: a highly selective endogenous opioid agonist for presynaptic mu opioid receptors.
Schoffelmeer AN; Warden G; Hogenboom F; Mulder AH
J Pharmacol Exp Ther; 1991 Jul; 258(1):237-42. PubMed ID: 1677039
[TBL] [Abstract][Full Text] [Related]
6. Opioid receptor antagonists discriminate between presynaptic mu and delta receptors and the adenylate cyclase-coupled opioid receptor complex in the brain.
Schoffelmeer AN; De Vries TJ; Hogenboom F; Hruby VJ; Portoghese PS; Mulder AH
J Pharmacol Exp Ther; 1992 Oct; 263(1):20-4. PubMed ID: 1328606
[TBL] [Abstract][Full Text] [Related]
7. Kappa1- and kappa2-opioid receptors mediating presynaptic inhibition of dopamine and acetylcholine release in rat neostriatum.
Schoffelmeer AN; Hogenboom F; Mulder AH
Br J Pharmacol; 1997 Oct; 122(3):520-4. PubMed ID: 9351509
[TBL] [Abstract][Full Text] [Related]
8. Characterization of dopamine receptors mediating inhibition of adenylate cyclase activity in rat striatum.
Onali P; Olianas MC; Gessa GL
Mol Pharmacol; 1985 Aug; 28(2):138-45. PubMed ID: 2410769
[TBL] [Abstract][Full Text] [Related]
9. Interactions among mu- and delta-opioid receptors, especially putative delta1- and delta2-opioid receptors, promote dopamine release in the nucleus accumbens.
Hirose N; Murakawa K; Takada K; Oi Y; Suzuki T; Nagase H; Cools AR; Koshikawa N
Neuroscience; 2005; 135(1):213-25. PubMed ID: 16111831
[TBL] [Abstract][Full Text] [Related]
10. Mu and delta opioid receptor desensitization in undifferentiated human neuroblastoma SHSY5Y cells.
Prather PL; Tsai AW; Law PY
J Pharmacol Exp Ther; 1994 Jul; 270(1):177-84. PubMed ID: 8035314
[TBL] [Abstract][Full Text] [Related]
11. Cross-linking of human [125I]beta-endorphin to opioid receptors in rat striatal membranes: biochemical evidence for the existence of a mu/delta opioid receptor complex.
Schoffelmeer AN; Yao YH; Gioannini TL; Hiller JM; Ofri D; Roques BP; Simon EJ
J Pharmacol Exp Ther; 1990 Apr; 253(1):419-26. PubMed ID: 2158552
[TBL] [Abstract][Full Text] [Related]
12. Potentiation of dopamine D1-like receptor signaling by concomitant activation of δ- and μ-opioid receptors in mouse medial prefrontal cortex.
Olianas MC; Dedoni S; Onali P
Neurochem Int; 2012 Dec; 61(8):1404-16. PubMed ID: 23073238
[TBL] [Abstract][Full Text] [Related]
13. Mu-opioid receptors mediate the inhibitory effect of opioids on dopamine-sensitive adenylate cyclase in primary cultures of rat neostriatal neurons.
Van Vliet BJ; Mulder AH; Schoffelmeer AN
J Neurochem; 1990 Oct; 55(4):1274-80. PubMed ID: 2168934
[TBL] [Abstract][Full Text] [Related]
14. Intermittent morphine administration induces a long-lasting synergistic effect of corticosterone on dopamine D1 receptor functioning in rat striatal GABA neurons.
Schoffelmeer AN; De Vries TJ; Vanderschuren LJ; Tjon GH; Nestby P; Wardeh G; Mulder AH
Synapse; 1997 Apr; 25(4):381-8. PubMed ID: 9097397
[TBL] [Abstract][Full Text] [Related]
15. Delta and mu opioid receptors from the brain of a urodele amphibian, the rough-skinned newt Taricha granulosa: cloning, heterologous expression, and pharmacological characterization.
Bradford CS; Walthers EA; Stanley DJ; Baugh MM; Moore FL
Gen Comp Endocrinol; 2006 May; 146(3):275-90. PubMed ID: 16375901
[TBL] [Abstract][Full Text] [Related]
16. Blockade of D-2 dopamine receptors strongly enhances the potency of enkephalins to inhibit dopamine-sensitive adenylate cyclase in rat neostriatum: involvement of delta- and mu-opioid receptors.
Schoffelmeer AN; Hansen HA; Stoof JC; Mulder AH
J Neurosci; 1986 Aug; 6(8):2235-9. PubMed ID: 3018189
[TBL] [Abstract][Full Text] [Related]
17. Differences among mouse strains in the regulation by mu, delta 1 and delta 2 opioid receptors of striatal adenylyl cyclases activated by dopamine D1 or adenosine A2a receptors.
Noble F; Cox BM
Brain Res; 1996 Apr; 716(1-2):107-17. PubMed ID: 8738226
[TBL] [Abstract][Full Text] [Related]
18. Mu-opioid receptor-mediated inhibition of D-1 dopamine receptor stimulated adenylate cyclase in primary cultures of rat neostriatal neurons.
van Vliet BJ; Mulder AH; Schoffelmeer AN
Prog Clin Biol Res; 1990; 328():409-12. PubMed ID: 2154799
[No Abstract] [Full Text] [Related]
19. Ontogeny of mu-, delta- and kappa-opioid receptors mediating inhibition of neurotransmitter release and adenylate cyclase activity in rat brain.
De Vries TJ; Hogenboom F; Mulder AH; Schoffelmeer AN
Brain Res Dev Brain Res; 1990 Jun; 54(1):63-9. PubMed ID: 2163782
[TBL] [Abstract][Full Text] [Related]
20. Modulation of dopamine release in rat striatal slices by delta opiate agonists.
Lubetzki C; Chesselet MF; Glowinski J
J Pharmacol Exp Ther; 1982 Aug; 222(2):435-40. PubMed ID: 6284911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
